Regulation of tissue plasminogen activator production in cultured human fetal mesangial cells

Experimental Nephrology

Volumn 6, Issue 6, 1998, Pages 508-513

  Yoshiko, Baba ^a   Yamabe, Hideaki ^a   Osawa, Hiroshi ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Mesangial cells; Thrombin; Tissue plasminogen activator; Transforming growth factor

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FETUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031773287     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020565     Document Type: Article

References (28)

1. Moll S, Menoud PA, Fulius T, Pastore Y, Takahashi S, Fossati L, Vassalli JD, Sappino AP, Schifferli JA, Izui S: Induction of plasminogen activator inhibitor type 1 in murin lupus-like glomerulonephritis. Kidney Int 1995;48:1459-1468.
2. Tomooka S, Border WA, Marshall BC, Noble NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 1992;42:1462-1469.
3. Wardle EN: Cytokine growth factors and glomerulonephritis. Nephron 1991;57:257-261.
4. Yamamoto T, Nobel NA, Miller DE, Border WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-927.
5. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Am Soc Clin Invest 1990;86:453-462.
6. Yoshida K, Takemura T, Murakami K, Okuda M, Hino S, Miyamoto H, Maki S: Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidney. Lab Invest 1993;68:154-163.
7. Border WA, Ruoslahti E: Transforming Growth factor-β in disease: The dark side of tissue repair. Am Soc Clin Invest 1992;90:1-7.
8. Cao HJ, Hogg MG, Martino U, Smith TJ: Transforming growth factor-beta induces plasminogen activator inhibitor type-1 in cultured human orbital fibroblasts. Invest Ophthalmol Vis Sci 1995;36:1411-1419.
9. Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ: Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA and protein in rat osteoblast-like cells. J Cell Physiol 1991;149:34-43.
10. Rogister B, Delree P, Leprince P, Martin D, Sadzoi C, Malgrange B, Munaut C, Rigo JM, Lefebvre PP, Octave JN: Transforming growth factor beta as a neuronoglial signal during peripheral nervous system response to injury. J Neurosci Res 1993;34:32-43.
11. Lacave R, Rondeau E, Ochi S, Delarue F, Schleuning WD, Sraer JD: Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int 1989;35: 806-811.
12. Gordon EA, Carney DH: Thrombin receptor occupancy initiates cell proliferation in the presence of phorbol myristate acetate. Biochem Biophys Res Commun 1986;141:650-656.
13. Carney DH, Scott DL, Gordon EA, Labelle EF: Phosphoinositides in mitogenesis: Neomycin inhibits thrombin-stimulated phosphoinositide turnover and initiation of cell proliferation. Cell 1985;42:479-488.
14. Chen LB, Teng NNH, Buchanan JM: Mitogenicity of thrombin and surface alterations on mouse splenocytes. Exp Cell Res 1976;101:41-46.
15. Herbert JM, Dupuy E, Laplace MC, Zini JM, Bar-Shavit R, Tobelem G: Thrombin induces endothelial cell growth via both a proteolytic and a nonproteolylic pathway Biochem J 1994;303:227-231.
16. Weiss RH, Maduri M: The mitogenic effect of thrombin in vascular smooth muscle cells is largerly due to basic fibroblast growth factor. J Biol Chem 1993;15:5724-5727.
17. Kanthou C, Parry G, Wijelath E, Kakkar VV, Demoliou-Mason C: Thrombin-induced proliferation and expression of platelet-derived growth factor A chain gene in human vascular smooth muscle cells. FEBS Lett 1992;314:143-148.
18. Shultz PJ, Knauss TC, Mene P, Abboud HE: Mitogenic signals for thrombin in mesangial cells: Regulation of phospholipase C and PDGF genes. Am J Physiol 1989;257:F366-F374.
19. Albrightson CR, Nambi P, Zabko-Potapovich B, Dytko G, Groom T: Effect of thrombin on proliferation, contraction and prostagrandin production of rat glomerular mesangial cells in culture. J Pharmacol Exp Ther 1992;263:404-412.
20. He CJ, Rondeau E, Medcalf RL, Lacave R, Schleuning WD, Sraer JD: Thrombin stimulates proliferation and decreases fiblynolytic activity of human glomerular epithelial cells. J Cell Physiol 1991;146:131-140.
21. Villamediana LM, Rondeau E, He CJ, Medcalf RL, Peraldi MN, Lacave R, Delarue F, Sraer JD: Thrombin regulates components of the fibrinolytic system in human mesangial cells. Kidney Int 1990;38:956-961.
22. Striker GE, Striker LJ: Biology of disease: Glomerular culture. Lab Invest 1985;53:122-131.
23. Ranby M, Norrman B, Wallen P: A sensitive assay for tissue plasminogen activator. Thromb Res 1982;27:743-749.
24. Lowry O, Rosebrough NJ, Farr AL: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
25. Roger CW, Nnennaya N, John RS: Tissue factor production by cultured rat mesangial cells. Stimulation by TNF α and lipopolysaccharide. Kidney Int 1990;37:1281-1285.
26. Vassalli JD, Sappino AP, Belin D: The plasminogen activator/plasmin system. J Clin Invest 1991;88:1067-1072.
27. Newman MJ, Lane EA, Iannotti AM, Nugent MA, Pepinsky RB, Keski-Oja J: Characterization and purification of a secreted plasminogen activator inhibitor (PAI-1) induced by transforming growth factor-β1 in normal rat kidney (NRK) cells: Decreased PAI-1 expression in transformed NRK cells. Endocrinology 1990; 126:2936-2946.
28. Hagege J, Peraldi MN, Rondeau E, Adida C, Delarue F, Medcalf R, Schleuning WD, Sraer JD: Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells. Am J Pathol 1992;141: 117-128.